Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
2,701	61.366	1	female	0	26	527	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	0	66,701	42,294.8125	44,193.1562	32.5	white	42.796875	69	0.397949	0.278992	1	0	0	no	0.8	0.7	no dnr	26	83	15.798828	80	20	36.39844	248	4.099609	0.399963	0.899902	137	7.389648	170	20	2,400	null	0	no(M2 and SIP pres)	0
2,702	82.92999	1	female	0	14	167	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	20,326	13,601.4219	14,092.8281	9.666664	white	15.599609	29	0.85791	0.80896	1	0	0	no	0.75	0.6	no dnr	14	73	7.199219	60	15	35.79688	null	null	null	2	142	null	105	41	1,275	3	0	no(M2 and SIP pres)	0
2,703	83.88196	0	female	0	35	864	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	under $11k	0	83,738	31,256.8594	60,927.0625	38.25	black	30.699219	43	0.521973	0.405945	5	0	0	no	0.2	0.2	no dnr	35	111	2.799805	105	38	36.69531	151.65625	2.599609	1.699951	3.799805	145	7.40918	340	73	3,525	null	0	no(M2 and SIP pres)	0
2,704	68.50397	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	36,125	14,889.1406	26,628.0469	46	white	49.59375	70	0.158997	0.077988	1	0	0	no	0.3	0.3	dnr after sadm	6	67	22.5	120	40	35.69531	190	null	null	0.899902	145	7.469727	140	8	596	null	0	<2 mo. follow-up	0
2,705	74.91595	0	male	0	5	862	CHF	COPD/CHF/Cirrhosis	4	14	under $11k	0	6,488	2,851.5176	4,412.05859	19	white	15.298828	7	0.880981	0.80188	1	0	0	no	0.7	0.6	no dnr	5	64	22.199219	72	8	36.39844	122	null	null	1.099854	132	7.429688	263	18	1,655	0	1	null	1
2,706	41.26797	1	male	1	35	35	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	under $11k	0	54,511	24,352.5781	39,397.0312	25.75	white	40.398438	53	0.5979	0.490967	1	1	0	no	0.5	0.5	dnr after sadm	11	51	0.899902	108	31	35.59375	245.6875	2.5	1	1	141	7.40918	133	17	2,000	null	0	<2 mo. follow-up	0
2,707	90.18799	0	female	0	31	862	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	56,886	43,806.9062	46,281.8125	17.25	white	28.5	32	0.512939	0.395996	10	0	0	no	0.9	0.9	no dnr	31	110	15	80	20	37.19531	169.375	3	null	1.699951	139	7.299805	103	30	3,175	1	0	no(M2 and SIP pres)	0
2,708	62.80899	1	male	1	53	53	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	110,359	65,038.4375	83,454.875	24.75	white	24.796875	32	0.770996	0.696899	4	0	0	no	0.5	0.3	no dnr	53	83	2.799805	72	18	36.29688	null	2.899902	0.599976	1	133	null	94	9	2,500	null	0	<2 mo. follow-up	0
2,709	81.862	0	male	0	7	859	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	$11-$25k	0	13,348	5,834.8086	7,087.40625	11	white	24.898438	43	0.665894	0.56897	1	0	0	yes	0.95	0.9	no dnr	7	53	10.898438	80	15	38.89844	null	1.899902	null	13.199219	141	null	96	52	0	1	1	no(M2 and SIP pres)	1
2,710	92.59998	1	male	0	4	424	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	4,591	2,519.8281	2,690.46875	15	white	16.597656	25	0.767944	0.630981	1	0	0	yes	0.7	0.5	no dnr	4	63	14.599609	120	30	36.69531	216.65625	3.699707	0.5	0.799927	145	7.359375	100	9	null	0	null	SIP>=30	0.494751
2,711	63.23297	1	male	0	17	200	Colon Cancer	Cancer	2	9	null	0	21,338	12,039.3906	10,617.6875	14.666664	white	19.296875	23	0.787964	0.554932	1	0	0	metastatic	0.95	0.5	dnr after sadm	10	103	14.898438	80	20	36.09375	142.84375	null	null	1	136	7.339844	115	39	2,300	1	0	no(M2 and SIP pres)	0
2,712	37.16599	0	male	0	35	857	Cirrhosis	COPD/CHF/Cirrhosis	2	12	null	9	41,987	22,330.9375	10,011.1328	12	white	50	85	0.214996	0.068985	1	0	0	no	0.5	0.4	no dnr	35	97	14	80	25	36.69531	204.75	null	null	1.099854	143	7.369141	131	16	null	1	3	no(M2 and SIP pres)	3
2,713	75.409	0	male	0	8	856	ARF/MOSF w/Sepsis	ARF/MOSF	4	9	under $11k	0	33,492	15,391.3984	15,235.4844	9.5	white	17.097656	15	0.813965	0.751953	15	1	0	no	0.9	0.85	no dnr	8	66	6.399414	116	8	36.09375	222	3	1.199951	3.799805	142	7.209961	112	58	4,150	0	null	no(M2 and SIP pres)	0.494751
2,714	72.534	1	male	0	5	29	COPD	COPD/CHF/Cirrhosis	3	8	null	9	6,225	3,391.3731	3,447.21875	16	white	25.796875	27	0.645996	0.46698	1	0	0	yes	0.3	0.1	no dnr	5	61	23.199219	130	10	38.69531	270	null	null	1.199951	147	7.389648	155	46	2,159	null	4	<2 mo. follow-up	4
2,715	80.66296	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	67,475	23,792.2969	46,603.875	56	white	30.199219	52	0.618896	0.514893	1	0	0	no	0.1	0.1	dnr after sadm	16	69	12.099609	125	28	35.59375	149	3.699707	null	6.199219	123	7.179688	159	89	1,395	null	null	<2 mo. follow-up	2.294434
2,716	75.90698	0	male	0	21	855	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	61,597	38,251.2812	40,254.4688	46	white	35.695313	52	0.503906	0.386963	1	0	0	no	0.05	0.05	no dnr	21	63	7.599609	64	26	36.59375	285	null	null	1	141	7.399414	130	23	1,350	null	0	SIP>=30	0
2,717	88.99396	1	male	0	10	293	COPD	COPD/CHF/Cirrhosis	3	16	null	0	16,074	6,716.0938	12,173.6328	16	white	27.898438	41	0.531982	0.33197	1	0	0	no	0.7	0.5	dnr before sadm	-1	55	33	76	11	36.19531	88	2	null	0.699951	147	7.379883	116	11	3,531	0	null	no(M2 and SIP pres)	0.494751
2,718	52.73398	0	male	0	59	853	Coma	Coma	1	null	null	0	70,943	41,053.25	15,052.4062	19	white	25.296875	41	0.727905	0.677979	2	0	0	no	0.5	0.5	dnr after sadm	54	45	2.099609	118	20	38.69531	98.75	3.599609	4	2.5	138	7.279297	121	54	1,300	null	null	null	1.712891
2,719	80.37195	1	female	0	21	120	ARF/MOSF w/Sepsis	ARF/MOSF	1	17	$25-$50k	0	42,111	29,083.7656	30,119.0469	35.666657	white	22	31	0.782959	0.712891	1	0	0	no	0.85	0.8	no dnr	21	107	7	70	20	36.09375	206.65625	3.799805	0.899902	1.299805	144	7.469727	95	16	2,200	null	null	SIP>=30	2.895996
2,720	80.24097	1	female	0	16	419	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	26,305	11,489.6016	16,048.9297	16	white	30.5	46	0.509888	0.392944	2	0	0	yes	0.9	0.9	no dnr	16	43	5.899414	117	42	39.19531	108	2.599609	0.5	1.299805	136	7.439453	215	19	3,770	1	0	no(M2 and SIP pres)	0
2,721	50.46698	0	male	0	8	851	COPD	COPD/CHF/Cirrhosis	4	10	under $11k	0	11,153	4,478.0234	8,908.04688	18	black	15.398438	13	0.925903	0.873901	1	0	0	yes	0.7	0.6	no dnr	8	60	15.898438	60	24	36.29688	91.65625	2.299805	null	1.699951	139	7.429688	113	34	3,075	0	0	no(M2 and SIP pres)	0
2,722	70.20898	1	male	0	14	279	Cirrhosis	COPD/CHF/Cirrhosis	1	12	$25-$50k	0	18,113	10,003.5156	8,457.25781	5.333332	white	17.296875	37	0.773926	0.639893	1	0	0	no	0.8	0.6	no dnr	14	103	5.199219	68	22	37.69531	263.3125	null	null	3.5	131	7.40918	245	65	2,395	1	2	SIP>=30	2
2,723	79.71497	1	female	0	19	26	COPD	COPD/CHF/Cirrhosis	7	12	under $11k	26	18,665	11,108.2734	10,894.8672	10	white	21.699219	31	0.599976	0.409973	1	1	1	yes	0.5	0.2	dnr before sadm	-1	59	10.599609	69	20	36.69531	178.3125	3.599609	1.799805	2.399902	138	7.15918	85	33	850	null	7	<2 mo. follow-up	7
2,724	38.39798	0	male	0	127	850	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	under $11k	0	308,151	174,160.875	205,494.25	48.25	white	33.898438	44	0.674927	0.579956	14	0	1	no	0.5	0.5	no dnr	127	103	5.599609	70	20	36.69531	null	null	null	1.699951	143	null	103	32	1,310	null	3	adl>=4 (>=5 if sur)	3
2,725	72.487	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	86,066	48,466.7188	51,779.4375	37	black	39.398438	67	0.292969	0.181976	23	0	1	no	0.7	0.5	dnr before sadm	0	63	6.099609	80	20	36.09375	null	null	1.599854	1.899902	135	null	98	27	2,000	null	null	<2 mo. follow-up	4.946289
2,726	71.17896	1	female	0	12	408	Lung Cancer	Cancer	2	16	$25-$50k	0	17,762	11,561.0938	10,735.1094	27.5	black	16.296875	26	0.707886	0.424988	1	1	0	metastatic	0.75	0.5	no dnr	12	56	26.097656	72	28	36.09375	null	1.299805	24.398438	2.399902	112	null	477	28	1,040	0	0	no(M2 and SIP pres)	0
2,727	63.767	0	female	0	26	848	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	59,345	33,678.8438	40,554.8438	28.75	white	17.199219	20	0.87793	0.834961	2	1	0	no	0.5	0.75	no dnr	26	80	6.199219	80	20	36.09375	266.625	2.5	null	0.899902	134	7.5	124	11	1,100	1	0	no(M2 and SIP pres)	0
2,728	91.98395	1	female	0	3	658	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	0	5,355	2,215.8594	3,479.26953	null	white	14.798828	10	0.842896	0.78894	1	0	0	no	null	null	dnr after sadm	1	107	8.298828	80	15	36.09375	484	2.5	null	2.399902	138	7.339844	192	36	1,300	null	null	no(M2 and SIP pres)	2.695801
2,729	70.87994	1	male	0	6	42	Lung Cancer	Cancer	3	12	null	0	5,514	3,357.1543	3,557.30859	11	white	31.597656	31	0.301941	0.051994	1	0	0	metastatic	0.8	0.3	no dnr	6	119	9.599609	140	12	34.59375	150	2.199707	null	0.799927	144	7.429688	90	54	2,955	4	5	<2 mo. follow-up	5
2,730	77.65399	0	female	0	10	844	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	14,591	6,149.5938	10,684.1562	15	white	25.898438	25	0.727905	0.643921	1	1	0	no	0.9	0.8	no dnr	10	53	13.199219	72	10	38.29688	80	2.599609	null	2.599609	130	7.319336	121	62	2,362	null	null	null	3.114746
2,731	59.58398	1	male	0	48	258	MOSF w/Malig	ARF/MOSF	1	20	>$50k	0	106,109	59,733.1875	68,911.875	24.5	white	34.5	58	0.352966	0.235992	1	0	0	metastatic	0.9	0.8	no dnr	48	61	7.5	112	40	37.59375	122.4375	3.199707	null	0.899902	141	7.399414	139	39	1,130	null	0	no(M2 and SIP pres)	0
2,732	42.69998	0	male	0	4	845	COPD	COPD/CHF/Cirrhosis	3	14	under $11k	0	6,088	1,507.1191	6,243.46875	5	hispanic	17.5	27	0.946899	0.908936	1	0	0	no	0.98	0.96	no dnr	4	107	12.398438	111	36	38.79688	156	3.699707	null	0.899902	145	7.459961	105	31	1,640	0	null	null	0.494751
2,733	40.745	0	male	0	12	843	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	$11-$25k	0	21,615	8,890.4766	13,112.7344	16	white	23.296875	34	0.881958	0.839966	1	0	0	no	0.7	0.65	no dnr	12	60	20.796875	114	32	37.89844	220	null	null	1.199951	134	7.479492	116	23	2,878	0	null	null	0.494751
2,734	84.58899	1	male	0	7	273	CHF	COPD/CHF/Cirrhosis	2	17	$25-$50k	0	12,772	5,564.2031	5,248.6875	14	white	18.199219	22	0.820923	0.707886	1	0	0	no	0.75	0.5	no dnr	7	53	22.597656	69	28	38	234.28125	3.099609	0.5	6.699219	127	7.369141	162	84	2,260	0	0	no(M2 and SIP pres)	0
2,735	38.21997	1	female	0	65	781	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	165,549	97,381.375	96,217.125	24	black	27.898438	64	0.794922	0.727905	9	0	0	no	0.7	0.6	no dnr	65	113	6.899414	65	13	36.29688	null	3.699707	0.5	0.899902	139	null	176	11	2,400	null	null	no(M2 and SIP pres)	2.452148
2,736	66.57098	1	female	0	17	251	MOSF w/Malig	ARF/MOSF	2	8	under $11k	9	21,336	10,116.6641	14,810.6953	10.666664	hispanic	20	38	0.74292	0.661987	1	0	0	yes	1	0.9	no dnr	17	83	6.099609	80	20	36.09375	null	3.299805	1.699951	1.599854	138	null	65	30	300	2	0	no(M2 and SIP pres)	0
2,737	72.09296	1	female	1	66	66	Coma	Coma	2	12	$11-$25k	61	92,723	53,217.9375	72,852.375	19	black	18.199219	37	0.385986	0.311951	15	1	0	no	0.8	0.75	dnr after sadm	12	93	8.699219	70	20	36.09375	null	null	0.399963	6.5	133	null	111	97	1,200	null	2	null	2
2,738	42.99799	0	male	0	23	839	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	58,702	33,407.1562	37,522.1562	26	white	35.59375	52	0.623901	0.519897	9	0	0	no	0.5	0.5	no dnr	23	55	16.898438	78	10	35	65	2	0.599976	0.599976	137	7.389648	144	4	1,906	0	0	null	0
2,739	68.88196	1	male	0	7	177	COPD	COPD/CHF/Cirrhosis	4	13	$11-$25k	0	8,507	4,556.7773	5,845.58984	7	white	20.296875	47	0.758911	0.618896	1	1	0	metastatic	0.8	0.6	no dnr	7	60	11.599609	80	36	33.79688	96.65625	2.5	2.099609	2.399902	149	7.529297	85	54	1,735	1	0	no(M2 and SIP pres)	0
2,740	70.20398	0	female	0	6	837	COPD	COPD/CHF/Cirrhosis	4	11	$11-$25k	0	6,931	3,673.6504	1,297.81934	13	white	20.097656	29	0.838989	0.735962	1	0	0	no	0.95	0.9	no dnr	6	107	4.599609	69	28	38.19531	null	null	null	1.5	134	null	333	17	3,480	2	null	no(M2 and SIP pres)	1.838867
2,741	92.33899	1	female	0	24	147	ARF/MOSF w/Sepsis	ARF/MOSF	3	18	under $11k	0	34,012	20,204.1719	21,715.9844	22.666656	white	26.898438	51	0.630981	0.527954	1	1	0	no	0.75	0.75	no dnr	24	52	8.5	81	8	38.89844	295	null	null	1.099854	139	7.419922	101	18	2,212	0	null	SIP>=30	0.494751
2,742	85.34399	0	female	0	30	836	Coma	Coma	2	null	null	26	41,743	23,544.8438	22,831.5	17	white	17.5	30	0.483948	0.41095	1	0	0	yes	0.3	0.1	dnr after sadm	1	93	6.799805	60	20	37.59375	318	null	null	1	141	7.5	95	26	null	null	3	adl>=4 (>=5 if sur)	3
2,743	87.71497	1	male	1	3	3	Coma	Coma	0	null	null	0	7,018	5,242.0508	5,069.41797	17	white	41.195313	89	0.056	0.028999	1	0	0	no	null	null	dnr after sadm	1	80	20.597656	110	25	37.79688	null	2.599609	null	1.199951	133	null	93	21	1,475	null	null	<2 mo. follow-up	2.151856
2,744	49.155	1	male	0	21	32	Cirrhosis	COPD/CHF/Cirrhosis	7	16	>$50k	0	46,039	26,825.8281	26,029.7969	22.666656	white	28.796875	46	0.706909	0.546997	1	1	0	no	0.8	0.75	dnr after sadm	13	60	22.199219	108	30	38.59375	135	2.899902	1.399902	1	136	7.319336	164	26	2,140	3	3	<2 mo. follow-up	3
2,745	87.44397	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	7,418	2,254.0938	6,433.62891	17	white	34.59375	69	0.369995	0.251953	1	0	0	yes	0	0	dnr after sadm	1	45	7.699219	54	26	38.79688	170	2	7.399414	0.899902	139	7.379883	88	40	2,450	null	null	<2 mo. follow-up	2.854981
2,746	71.74799	0	female	0	16	829	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	0	68,313	34,881.2188	36,946.6875	26	white	22.199219	37	0.80896	0.745972	1	1	0	no	0.6	0.5	no dnr	16	74	6	72	24	36.79688	176.1875	null	null	0.799927	137	7.289062	98	8	1,650	0	0	no(M2 and SIP pres)	0
2,747	32.75598	0	female	0	16	828	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	under $11k	0	22,857	12,762.8438	4,844.19922	21	white	28.296875	40	0.849976	0.79895	1	0	0	no	0.99	0.99	no dnr	16	147	11.298828	78	6	38.39844	89	3.199707	0.699951	1.199951	147	7.339844	149	31	2,090	1	1	SIP>=30	1
2,748	80.22498	1	female	0	8	23	Lung Cancer	Cancer	1	12	under $11k	0	7,970	4,700.3672	4,924.38672	2	white	20.199219	37	0.594971	0.276978	1	0	0	metastatic	0.8	0.3	dnr after sadm	1	77	6.799805	80	25	36.39844	136.65625	4.099609	0.799927	1.399902	141	7.319336	104	23	2,720	1	6	<2 mo. follow-up	6
2,749	79.65796	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	2	null	null	0	9,602	6,555.2578	5,145.31641	8	white	30.5	59	0.430969	0.310974	1	1	0	metastatic	0.1	0	dnr after sadm	1	127	15	110	8	36.39844	194	2	null	6.199219	137	7.419922	73	44	95	null	3	<2 mo. follow-up	3
2,750	74.72095	0	male	0	4	824	CHF	COPD/CHF/Cirrhosis	3	16	>$50k	0	5,136	2,833.5059	2,667.56836	9	white	17.796875	29	0.856934	0.764893	1	1	0	no	0.2	0.1	no dnr	4	61	9.699219	108	32	36.69531	266.625	2.299805	1.099854	1.299805	143	7.55957	145	21	1,160	null	null	no(M2 and SIP pres)	2.106445
2,751	68.50696	1	female	0	12	41	Lung Cancer	Cancer	1	12	null	0	12,682	7,578.1133	7,094.25	7.5	white	6.899414	16	0.853882	0.67688	1	0	0	metastatic	0.7	0.2	no dnr	12	67	8.898438	76	24	36.59375	306.0625	null	null	2.299805	139	7.419922	298	33	928	null	null	<2 mo. follow-up	2.239746
2,752	59.79498	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	6	null	null	0	33,532	22,360.375	17,212.5156	35	black	35.398438	67	0.588989	0.480957	2	1	0	no	0.6	0.4	dnr after sadm	5	48	55.59375	70	0	38.19531	128	null	null	0.799927	131	7.419922	144	9	4,675	null	null	<2 mo. follow-up	3.238281
2,753	92.32599	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	21,252	14,635.0859	11,433.4688	35	white	32.398438	60	0.487976	0.369995	1	0	1	no	0.25	0.25	dnr before sadm	0	101	7.599609	60	28	36.09375	163.3125	3.699707	0.599976	0.899902	139	7.469727	227	12	1,850	null	null	<2 mo. follow-up	6.123047
2,754	73.63696	0	female	0	9	821	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	8,924	5,092.6602	5,050.61719	10	white	17.699219	20	0.860962	0.769897	1	1	0	no	0.9	0.75	no dnr	9	83	6.099609	100	25	35.59375	271.375	null	null	1.199951	142	7.419922	103	28	800	1	2	SIP>=30	2
2,755	82.57397	0	male	0	14	821	ARF/MOSF w/Sepsis	ARF/MOSF	1	17	$11-$25k	0	52,314	27,385.3438	25,607.7344	13	white	24.296875	30	0.734985	0.651978	1	0	0	no	0.7	0.5	no dnr	14	115	12.599609	156	14	36.29688	252.375	2.699707	null	2.399902	139	7.469727	146	55	1,913	null	null	no(M2 and SIP pres)	3.111816
2,756	61.728	0	male	0	9	821	CHF	COPD/CHF/Cirrhosis	4	13	$11-$25k	0	12,263	6,591.2969	6,762.46875	18.5	white	18	16	0.860962	0.769897	1	0	0	yes	0.9	0.8	no dnr	9	135	13.898438	60	25	37.79688	238.09375	null	0.599976	1.299805	136	7.319336	108	25	2,170	0	0	no(M2 and SIP pres)	0
2,757	81.021	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	null	0	71,731	48,839.4062	46,667.0625	28.5	white	31	49	0.409973	0.289978	13	0	0	yes	0.1	0.1	no dnr	7	33	19.398438	68	44	40	347	null	null	2.199707	136	7.419922	547	39	64	null	0	<2 mo. follow-up	0
2,758	79.68195	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	2	null	null	0	44,745	26,816.8125	19,279.625	42.5	white	28.199219	35	0.577881	0.46698	1	0	0	yes	0.8	0.6	dnr after sadm	4	100	12.5	70	25	36.69531	428.5625	2.399902	7.299805	1.399902	126	7.549805	335	43	2,020	null	null	<2 mo. follow-up	2.443359
2,759	75.18695	0	female	0	5	819	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	null	0	7,456	4,245.8906	3,948.84961	14	black	22.898438	16	0.787964	0.718994	1	0	0	no	1	1	no dnr	5	46	15.898438	109	8	35.89844	238.09375	3.099609	null	1.599854	135	7.419922	204	26	253	0	0	no(M2 and SIP pres)	0
2,760	62.26099	1	male	0	14	120	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	0	39,981	21,077.875	16,336.7578	8.333328	white	24.199219	25	0.681885	0.588989	3	0	0	metastatic	0.5	0.1	dnr after sadm	2	111	7.199219	69	36	38.29688	196.65625	3.199707	null	2.799805	136	7.15918	272	36	2,115	2	0	no(M2 and SIP pres)	0
2,761	66.51294	0	female	0	5	818	COPD	COPD/CHF/Cirrhosis	5	null	null	0	4,732	2,705.3906	2,484.89844	10	white	17.699219	25	0.850952	0.753906	1	0	0	yes	0.9	0.8	no dnr	5	63	14	130	35	36.59375	150	2.299805	0.199982	0.799927	145	7.519531	111	12	1,180	null	null	null	3.896973
2,762	70.20099	0	female	0	11	817	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	22,622	13,765.7031	11,433.25	11	white	18.597656	29	0.85791	0.80896	1	0	0	no	0.95	0.95	no dnr	11	100	8.5	110	25	36.69531	null	3.399902	null	1.099854	137	null	209	28	800	0	0	no(M2 and SIP pres)	0
2,763	75.66296	1	female	0	24	74	Lung Cancer	Cancer	2	16	>$50k	0	30,159	16,960.3906	4,497.60938	7.666664	white	24.898438	17	0.482971	0.164978	1	1	0	metastatic	0.9	0.5	dnr after sadm	16	73	6.599609	120	35	35	457.125	2.899902	1	2.5	142	7.529297	227	61	550	1	3	adl>=4 (>=5 if sur)	3
2,764	73.06	0	female	0	10	816	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	31,491	16,079.4531	16,632.9375	30.5	white	23.398438	21	0.706909	0.61792	3	0	0	yes	1	1	no dnr	10	80	6.099609	80	25	36.69531	276.1875	null	null	1.799805	139	7.449219	116	41	null	0	1	no(M2 and SIP pres)	1
2,765	81.73297	1	female	0	13	47	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	28,287	21,679.875	19,889.0469	25	white	21.898438	45	0.727905	0.643921	1	0	1	yes	0.3	0.3	dnr after sadm	3	87	13.599609	68	20	36.5	null	4.299805	0.699951	0.899902	139	null	124	20	1,750	null	null	<2 mo. follow-up	5.37207
2,766	84.82098	1	female	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	2	18	>$50k	0	45,150	35,746.5	26,955.625	32.5	white	30.796875	46	0.578979	0.468994	1	0	1	no	0.8	0.8	dnr after sadm	7	53	14.798828	106	10	39.29688	108.32812	2.299805	0.599976	8.199219	147	7.429688	109	40	0	null	6	<2 mo. follow-up	6
2,767	49.82898	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	32,057	18,602.5156	16,752.6719	12	black	28.296875	34	0.658936	0.560913	3	0	1	metastatic	0	0	dnr after sadm	1	163	5.399414	150	37	38	72	2.5	0.599976	0.799927	142	7.369141	163	31	1,625	null	null	<2 mo. follow-up	4.806641
2,768	68.31995	0	male	0	7	813	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	15,734	11,297.625	8,246.88281	9.5	white	20.398438	24	0.843994	0.789917	1	0	0	no	0.9	0.9	no dnr	7	103	9.398438	60	20	36.09375	null	null	null	1.399902	140	null	129	44	2,275	0	1	no(M2 and SIP pres)	1
2,769	47.87399	0	male	0	28	813	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	null	0	124,925	87,454.0625	63,851.0625	39.5	white	40	55	0.569946	0.458984	1	0	0	no	0.1	0.1	no dnr	28	56	4.399414	48	22	36.09375	null	3.099609	0.599976	1.099854	143	null	106	14	1,370	null	1	no(M2 and SIP pres)	1
2,770	70.35199	1	female	0	17	118	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	9	100,587	59,188.5625	56,933.3438	11.333328	hispanic	21.699219	37	0.719971	0.633911	48	1	0	no	0.7	0.7	no dnr	17	83	7	80	35	35.59375	366.625	null	0.399963	1.199951	136	7.429688	107	14	2,980	1	1	no(M2 and SIP pres)	1
2,771	85.63196	0	male	0	19	811	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	55,663	null	null	21.333328	white	34.5	58	0.295959	0.184998	7	0	0	yes	0.8	0.7	no dnr	19	69	15.099609	66	20	36.09375	111.65625	2.099609	null	3.299805	139	7.439453	432	129	2,400	3	null	null	2.510742
2,772	64.08197	1	male	0	17	221	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	null	0	37,130	24,575.8281	15,632.1094	19	black	22.796875	45	0.768921	0.694946	2	1	0	yes	0.8	0.7	no dnr	17	63	7.099609	120	42	36.89844	135	3.199707	1.199951	0.799927	146	7.429688	131	17	1,010	0	0	no(M2 and SIP pres)	0
2,773	77.59296	1	male	0	14	17	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	null	9	37,632	24,508.875	21,132.0469	13.666664	white	22.398438	42	0.632935	0.529907	9	1	0	yes	0.25	0.05	dnr after sadm	1	101	4.899414	55	25	36.19531	266.625	4.399414	0.5	0.699951	144	7.439453	117	15	3,200	3	1	<2 mo. follow-up	1
2,774	76.78595	0	female	0	5	808	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	8,474	5,556.4961	4,709.59766	10	white	13.298828	30	0.893921	0.855957	1	0	0	no	0.99	0.9	no dnr	5	105	16	80	28	36.29688	138.3125	2.599609	0.799927	0.699951	142	7.40918	136	20	1,550	null	null	no(M2 and SIP pres)	1.78125
2,775	74.32996	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	6	12	$11-$25k	9	27,511	17,544.0156	9,628.41406	14.333328	white	19.699219	32	0.769897	0.695923	1	1	1	yes	0.1	0	dnr after sadm	3	100	null	90	25	36.09375	242.84375	null	0.299988	1.099854	133	7.359375	163	22	null	null	null	<2 mo. follow-up	5.783203
2,776	58.34598	1	male	0	13	690	Colon Cancer	Cancer	2	16	>$50k	0	20,169	11,726.9375	7,897.62891	15.5	white	15	16	0.852905	0.67395	1	0	0	metastatic	0.9	0.7	no dnr	13	82	27.398438	70	24	36.09375	197.125	2.699707	0.5	1.099854	138	7.369141	86	22	1,600	1	0	no(M2 and SIP pres)	0
2,777	52.98599	1	female	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	>$50k	41	165,799	115,003.688	82,986.625	38.5	white	30.597656	66	0.593994	0.485962	1	1	0	no	0.1	0.05	dnr after sadm	25	93	6.099609	60	15	37	null	2.799805	null	0.699951	134	null	249	25	null	null	4	<2 mo. follow-up	4
2,778	42.17899	0	male	0	28	802	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	95,443	63,887.2812	50,689.1875	23	black	24.898438	49	0.815918	0.753906	14	1	0	no	0.95	0.9	no dnr	28	110	4.899414	110	32	38.29688	183.3125	null	null	0.899902	143	7.489258	121	9	4,685	null	0	SIP>=30	0
2,779	70.11896	0	female	0	35	799	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	null	0	72,087	49,218.4688	40,064.7812	29	white	45.398438	63	0.260986	0.154999	1	0	0	no	0.25	0.15	no dnr	35	79	10.898438	140	38	38.09375	269.375	2.799805	0.599976	1.199951	138	7.379883	167	33	600	null	0	null	0
2,780	72.46497	1	male	0	13	31	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	$25-$50k	0	20,845	12,817.9688	6,751.56641	14	white	38.296875	44	0.363953	0.246979	1	0	0	yes	0.8	0.6	no dnr	13	48	10.398438	134	10	38.29688	170	null	null	1.299805	143	7.359375	121	32	505	0	0	<2 mo. follow-up	0
2,781	66.00397	1	female	0	8	30	MOSF w/Malig	ARF/MOSF	5	13	$11-$25k	0	20,343	14,605.9766	11,761.8984	20.5	hispanic	32.195313	42	0.408997	0.289978	1	1	0	metastatic	0.1	0	dnr after sadm	3	97	24.5	100	5	37.79688	111.65625	null	null	1.099854	137	7.449219	136	29	null	2	3	<2 mo. follow-up	3
2,782	72.38098	1	male	0	17	89	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	71,071	36,104.8125	34,603.875	15	white	31.699219	44	0.553955	0.440979	7	0	0	no	0.8	0.75	no dnr	17	129	5	106	34	38.19531	360	3.199707	1.399902	1.199951	142	7.449219	95	24	3,710	5	0	no(M2 and SIP pres)	0
2,783	74.875	1	female	0	7	190	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	7,262	3,990.8398	3,924.24805	12	other	13.699219	11	0.894897	0.823975	1	0	0	no	null	null	no dnr	7	47	18.597656	113	34	38.79688	53	2.299805	0.899902	0.899902	143	7.369141	154	17	1,968	1	1	no(M2 and SIP pres)	1
2,784	75.03094	0	female	0	27	794	COPD	COPD/CHF/Cirrhosis	2	null	null	0	59,400	40,212.1562	25,172.4688	19.5	white	23.597656	33	0.759888	0.618896	1	0	0	no	0.65	0.65	no dnr	27	99	24.199219	70	16	36.39844	334.25	null	0.799927	7.799805	137	7.359375	160	47	5	null	null	null	2.711914
2,785	30.752	0	female	0	39	793	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	107,237	49,841.0312	55,241.625	12.25	white	25.699219	22	0.86499	0.81897	3	0	0	no	0.9	0.729	no dnr	39	57	6	144	36	40.19531	111.65625	null	null	1.299805	134	7.40918	169	21	3,775	null	null	null	2.979492
2,786	93.008	1	female	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	30,466	23,195.1875	15,860.0391	27.5	white	15.199219	38	0.834961	0.778931	1	0	0	no	0.8	0.7	dnr after sadm	5	56	10.298828	68	30	36.09375	450	3.099609	null	1.599854	143	7.339844	112	58	950	null	7	<2 mo. follow-up	7
2,787	43.92297	0	female	0	5	793	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$25-$50k	0	8,939	5,789.7773	5,207.63672	12	white	18.699219	11	0.911987	0.879883	1	0	0	no	null	null	no dnr	5	120	14.298828	74	38	38.09375	null	2.699707	0.299988	3.799805	142	null	207	58	3,100	null	null	no(M2 and SIP pres)	1.797119
2,788	64.52795	0	female	0	7	792	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	13,593	7,954.3398	8,211.36719	10	white	24.097656	27	0.807983	0.743896	1	0	0	no	0.9	0.9	no dnr	7	97	6.899414	80	20	37.79688	261.875	null	null	0.899902	143	7.399414	87	21	250	0	0	no(M2 and SIP pres)	0
2,789	73.89496	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	32,243	18,343.7344	16,782.7188	25	white	49.195313	111	0.023998	0.006	1	0	0	metastatic	null	null	dnr before sadm	-1	76	5.399414	58	28	36.59375	361.875	2.899902	0.899902	1.099854	135	7.439453	133	39	492	null	null	<2 mo. follow-up	2.431152
2,790	47.16498	0	male	0	11	791	Cirrhosis	COPD/CHF/Cirrhosis	3	14	>$50k	0	23,887	18,863.2188	15,334.5156	12	white	21.597656	45	0.833984	0.728882	1	0	0	no	0.8	0.8	no dnr	11	103	4.699219	60	15	36.69531	null	null	0.599976	1.199951	138	null	114	20	null	0	0	no(M2 and SIP pres)	0
2,791	82.409	1	male	0	46	118	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	133,174	77,660.5	66,197.9375	31.25	white	17.699219	32	0.794922	0.727905	1	0	0	yes	0.99	0.95	dnr after sadm	22	150	31	102	38	36.29688	184	2	1.399902	1.5	127	7.40918	323	37	1,810	0	0	no(M2 and SIP pres)	0
2,792	65.58197	1	female	0	73	624	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	194,085	124,043.188	118,328.938	29.75	white	30.5	49	0.671997	0.576904	2	0	0	no	0.25	0.25	no dnr	73	119	8	119	28	39.59375	null	3.199707	1.599854	7.099609	140	null	151	22	0	null	2	adl>=4 (>=5 if sur)	2
2,793	52.89499	1	female	0	34	112	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$25-$50k	0	64,598	38,731.9062	33,413.875	16.5	white	31.699219	64	0.728882	0.645996	1	0	0	no	0.5	0.3	dnr after sadm	3	47	3.799805	108	26	36.39844	120	2	null	3.899902	136	7.419922	179	50	2,030	4	5	adl>=4 (>=5 if sur)	5
2,794	79.85199	1	female	0	28	525	MOSF w/Malig	ARF/MOSF	2	null	$11-$25k	0	38,248	22,160.5938	22,123.8438	14.75	white	26.597656	30	0.541992	0.427979	1	0	0	metastatic	0.8	0.75	dnr after sadm	4	52	10.099609	138	24	35	95	3.199707	null	1.399902	139	7.439453	132	38	1,550	null	1	SIP>=30	1
2,795	83.20898	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	23,733	15,129.2266	12,450.2266	35	white	35.898438	51	0.35498	0.237976	8	0	0	no	0.3	0.2	dnr after sadm	1	113	12	114	28	37.59375	75	null	null	0.699951	134	7.199219	256	7	2,275	5	0	<2 mo. follow-up	0
2,796	74.45898	1	female	1	65	65	Coma	Coma	2	9	null	0	268,852	152,357.875	144,530.25	42.5	white	31.398438	42	0.407959	0.333984	1	0	0	no	null	null	no dnr	65	55	6.099609	49	16	36.79688	146.9375	3.099609	null	2.699707	139	7.419922	103	29	1,365	null	null	null	1.988525
2,797	53.75497	1	female	0	14	82	Cirrhosis	COPD/CHF/Cirrhosis	4	4	under $11k	0	20,960	11,320.4219	10,513.7344	12.666664	white	19.898438	41	0.824951	0.713989	1	1	0	no	0.6	0.5	no dnr	14	93	4.399414	80	20	36.69531	246.65625	null	null	1.199951	140	7.439453	87	30	1,800	5	6	null	6
2,798	89.60699	1	female	0	6	211	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	11,821	null	null	23	white	31.097656	61	0.459961	0.339966	1	0	0	yes	0.5	0.2	no dnr	6	53	8.199219	68	8	36.69531	200	3	1.299805	0.699951	142	7.389648	111	32	1,050	2	null	adl>=4 (>=5 if sur)	1.838867
2,799	76.35297	1	male	0	6	622	COPD	COPD/CHF/Cirrhosis	2	12	null	0	78,784	41,778.3438	37,698.1875	14	white	22.5	34	0.616943	0.430969	26	0	0	yes	0.9	0.7	dnr after sadm	1	103	4.699219	120	28	38.79688	343.3125	null	1.099854	0.699951	132	7.399414	117	6	3,525	0	0	no(M2 and SIP pres)	0
2,800	68.42999	1	male	1	52	52	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	0	229,885	137,699.125	113,427.125	50.25	white	41.5	63	0.271973	0.164978	2	0	0	yes	0.6	0.6	dnr after sadm	14	63	8.099609	75	10	36.19531	230	2.799805	0.699951	1.099854	143	7.269531	196	53	850	null	2	<2 mo. follow-up	2

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.